Thor Medical ASA is an emerging supplier of isotopes for targeted alpha therapies in oncology. Its proprietary production technology eliminates the need for nuclear reactors and cyclotrons, offering a more efficient and environmentally sustainable approach to traditional methods.
By solving the supply challenges of key isotopes for the pharmaceutical market, Thor Medical is unlocking a new generation of alpha-emitting radioligand therapies for millions of cancer patients worldwide. The company is listed on the Oslo Stock Exchange under the ticker symbol TRMED.
Contact
Jasper C. Kurth,CEO
Mob: +47 974 14 000
E-mail: post@thormedical.no
Read more www.thormedical.no